ICSI versus standard IVF: indications and when it is essential

What is Intracytoplasmic Sperm Injection (ICSI)?

In conventional in vitro fertilisation (IVF), approximately 50,000 to 100,000 washed, motile sperm cells are placed in a droplet alongside a mature oocyte. The sperm must chemically digest the surrounding cumulus oophorus cells and physically penetrate the zona pellucida shell independently.

However, when sperm count is severely depleted (oligospermia), forward motility is sluggish (asthenospermia), or abnormal morphology predominates (teratospermia), natural penetration often fails completely, leading to total fertilisation failure (TFF).

ICSI bypasses natural penetration barriers entirely. Under high-magnification inverted microscopy (400x optical magnification), an experienced clinical embryologist isolates an individual, morphologically optimal sperm cell, immobilizes its tail using a micro-pipette tip, and gently aspirates it into a microscopic glass needle with an internal diameter of approximately 5 to 7 microns. The needle is then carefully passed through the egg's zona pellucida and oolemma membrane, depositing the sperm directly into the inner cytoplasm.

Clinical Indications: When is ICSI Medically Necessary?

ICSI is not automatically required for every couple undergoing assisted reproduction. Under guidelines from the American Society for Reproductive Medicine (ASRM) and ESHRE, ICSI is strictly indicated in:

• Severe Male Factor Parameters: Sperm counts below 5 million/mL, progressive motility under 20%, or normal forms under 4% (Kruger strict criteria).
• Surgically Retrieved Sperm: Epididymal (PESA) or testicular (TESA/Micro-TESE) sperm samples, which are immature and unable to penetrate the zona pellucida naturally.
• Previous Total or Low Fertilisation Failure: Couples who previously achieved <30% fertilisation in standard IVF cycles.
• Vitrified / Thawed Oocytes: Egg freezing procedures harden the zona pellucida shell during cryopreservation, making subsequent ICSI mandatory for reliable fertilisation.
• Preimplantation Genetic Testing (PGT): ICSI prevents extraneous sperm from adhering to the outer shell, eliminating paternal DNA contamination during laser embryo biopsy.

The Rescue ICSI Breakthrough (Pioneered by Dr. Suresh Kattera)

Historically, when eggs failed to fertilise in standard IVF, clinics had to discard the cycle or attempt "late rescue ICSI" 24 hours later, which frequently resulted in abnormal polyploidy and poor embryonic survival.

In 2003, Dr. Suresh Kattera published landmark clinical findings in *Human Reproduction*, demonstrating the world's first reported live births from Early Rescue ICSI. By inspecting eggs at an earlier window (6 hours post-insemination) for the absence of second polar body extrusion, unfertilized oocytes can be rescued with micro-injection before oocyte aging occurs, salvaging patient cycles that would otherwise have been complete failures.

Fertilisation Benchmarks & Realistic Outcomes

• Normal 2PN Fertilisation Rate: In skilled embryological hands, 70% to 80% of injected mature (MII) oocytes show normal two pronuclei (2PN) 16–18 hours post-injection.
• Oocyte Degeneration Rate: The oocyte membrane must tolerate mechanical puncture. In high-standard Class-100 cleanrooms with anti-vibration hydraulic micromanipulators, membrane lysis occurs in fewer than 5% of cells.
• Blastocyst Formation: Approximately 40% to 50% of normally fertilized 2PN embryos develop into viable Day-5 or Day-6 blastocysts.